Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population

Authors: Judy Y. Ou, Brynn Fowler, Qian Ding, Anne C. Kirchhoff, Lisa Pappas, Kenneth Boucher, Wallace Akerley, Yelena Wu, Kimberly Kaphingst, Garrett Harding, Deanna Kepka

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Lung cancer is the leading cause of cancer-related mortality in Utah despite having the nation’s lowest smoking rate. Radon exposure and differences in lung cancer incidence between nonmetropolitan and metropolitan areas may explain this phenomenon. We compared smoking-adjusted lung cancer incidence rates between nonmetropolitan and metropolitan counties by predicted indoor radon level, sex, and cancer stage. We also compared lung cancer incidence by county classification between Utah and all SEER sites.

Methods

SEER*Stat provided annual age-adjusted rates per 100,000 from 1991 to 2010 for each Utah county and all other SEER sites. County classification, stage, and sex were obtained from SEER*Stat. Smoking was obtained from Environmental Public Health Tracking estimates by Ortega et al. EPA provided low (< 2 pCi/L), moderate (2–4 pCi/L), and high (> 4 pCi/L) indoor radon levels for each county. Poisson models calculated overall, cancer stage, and sex-specific rates and p-values for smoking-adjusted and unadjusted models. LOESS smoothed trend lines compared incidence rates between Utah and all SEER sites by county classification.

Results

All metropolitan counties had moderate radon levels; 12 (63%) of the 19 nonmetropolitan counties had moderate predicted radon levels and 7 (37%) had high predicted radon levels. Lung cancer incidence rates were higher in nonmetropolitan counties than metropolitan counties (34.8 vs 29.7 per 100,000, respectively). Incidence of distant stage cancers was significantly higher in nonmetropolitan counties after controlling for smoking (16.7 vs 15.4, p = 0.02*). Incidence rates in metropolitan, moderate radon and nonmetropolitan, moderate radon counties were similar. Nonmetropolitan, high radon counties had a significantly higher incidence of lung cancer compared to nonmetropolitan, moderate radon counties after adjustment for smoking (41.7 vs 29.2, p < 0.0001*). Lung cancer incidence patterns in Utah were opposite of metropolitan/nonmetropolitan trends in other SEER sites.

Conclusion

Lung cancer incidence and distant stage incidence rates were consistently higher in nonmetropolitan Utah counties than metropolitan counties, suggesting that limited access to preventative screenings may play a role in this disparity. Smoking-adjusted incidence rates in nonmetropolitan, high radon counties were significantly higher than moderate radon counties, suggesting that radon was also major contributor to lung cancer in these regions. National studies should account for geographic and environmental factors when examining nonmetropolitan/metropolitan differences in lung cancer.
Literature
3.
go back to reference Torres-Duran M, Ruano-Ravina A, Parente-Lamelas I, Leiro-Fernandez V, Abal-Arca J, Montero-Martinez C, Pena-Alvarez C, Gonzalez-Barcala FJ, Castro-Anon O, Golpe-Gomez A, et al. Lung cancer in never-smokers: a case-control study in a radon-prone area (Galicia, Spain). Eur Respir J. 2014;44(4):994–1001.CrossRefPubMed Torres-Duran M, Ruano-Ravina A, Parente-Lamelas I, Leiro-Fernandez V, Abal-Arca J, Montero-Martinez C, Pena-Alvarez C, Gonzalez-Barcala FJ, Castro-Anon O, Golpe-Gomez A, et al. Lung cancer in never-smokers: a case-control study in a radon-prone area (Galicia, Spain). Eur Respir J. 2014;44(4):994–1001.CrossRefPubMed
4.
go back to reference Sethi TK, El-Ghamry MN, Kloecker GH. Radon and lung cancer. Clinical advances in hematology & oncology : H&O. 2012;10(3):157–64. Sethi TK, El-Ghamry MN, Kloecker GH. Radon and lung cancer. Clinical advances in hematology & oncology : H&O. 2012;10(3):157–64.
5.
go back to reference Centers for Disease Control and Prevention: Radon in the home. 2015. Centers for Disease Control and Prevention: Radon in the home. 2015.
6.
go back to reference Darby S, Hill D, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, Deo H, Falk R, Forastiere F, Hakama M, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (Clinical research ed). 2005;330(7485):223.CrossRef Darby S, Hill D, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, Deo H, Falk R, Forastiere F, Hakama M, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (Clinical research ed). 2005;330(7485):223.CrossRef
7.
go back to reference Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JI, et al. Residential radon and risk of lung cancer: a combined analysis of 7 north American case-control studies. Epidemiology (Cambridge, Mass). 2005;16(2):137–45.CrossRef Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JI, et al. Residential radon and risk of lung cancer: a combined analysis of 7 north American case-control studies. Epidemiology (Cambridge, Mass). 2005;16(2):137–45.CrossRef
8.
go back to reference Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JL, et al. A combined analysis of north American case-control studies of residential radon and lung cancer. Journal of toxicology and environmental health Part A. 2006;69(7):533–97.CrossRefPubMed Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JL, et al. A combined analysis of north American case-control studies of residential radon and lung cancer. Journal of toxicology and environmental health Part A. 2006;69(7):533–97.CrossRefPubMed
9.
go back to reference Zeeb H, Shannoun F. WHO handbook on indoor radon: a public health perspective [internet]. Geneva: World Health Organization; 2009. [cited 3 Feb 2012] Zeeb H, Shannoun F. WHO handbook on indoor radon: a public health perspective [internet]. Geneva: World Health Organization; 2009. [cited 3 Feb 2012]
10.
go back to reference Schubauer-Berigan MK, Daniels RD, Pinkerton LE. Radon exposure and mortality among white and American Indian uranium miners: an update of the Colorado plateau cohort. Am J Epidemiol. 2009;169(6):718–30.CrossRefPubMed Schubauer-Berigan MK, Daniels RD, Pinkerton LE. Radon exposure and mortality among white and American Indian uranium miners: an update of the Colorado plateau cohort. Am J Epidemiol. 2009;169(6):718–30.CrossRefPubMed
14.
go back to reference Leonard W. 1 in 3 Utah homes has cancer-causing radon at potentially harmful levels. In: Deseret Digital Media. Salt Lake City: Deseret Media Company; 2011. Leonard W. 1 in 3 Utah homes has cancer-causing radon at potentially harmful levels. In: Deseret Digital Media. Salt Lake City: Deseret Media Company; 2011.
18.
go back to reference Atkins GT, Kim T, Munson J. Residence in rural areas of the United States and lung cancer mortality: disease incidence, treatment disparities and stage specific survival. Annals of the American Thoracic Society. 2017;14:403–11.CrossRefPubMed Atkins GT, Kim T, Munson J. Residence in rural areas of the United States and lung cancer mortality: disease incidence, treatment disparities and stage specific survival. Annals of the American Thoracic Society. 2017;14:403–11.CrossRefPubMed
19.
go back to reference Fogleman AJ, Mueller GS, Jenkins WD. Does where you live play an important role in cancer incidence in the U.S.? Am J Cancer Res. 2015;5(7):2314–9.PubMedPubMedCentral Fogleman AJ, Mueller GS, Jenkins WD. Does where you live play an important role in cancer incidence in the U.S.? Am J Cancer Res. 2015;5(7):2314–9.PubMedPubMedCentral
20.
go back to reference Meilleur A, Subramanian SV, Plascak JJ, Fisher JL, Paskett ED, Lamont EB. Rural residence and cancer outcomes in the US: issues and challenges. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013;22(10). https://doi.org/10.1158/1055-9965. EPI-1113-0404. Meilleur A, Subramanian SV, Plascak JJ, Fisher JL, Paskett ED, Lamont EB. Rural residence and cancer outcomes in the US: issues and challenges. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013;22(10). https://​doi.​org/​10.​1158/​1055-9965. EPI-1113-0404.
21.
go back to reference Paquette I, Finlayson SR. Rural versus urban colorectal and lung cancer patients: differences in stage at presentation. J Am Coll Surg. 2007;205(5):636–41.CrossRefPubMed Paquette I, Finlayson SR. Rural versus urban colorectal and lung cancer patients: differences in stage at presentation. J Am Coll Surg. 2007;205(5):636–41.CrossRefPubMed
22.
go back to reference Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part II-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011;2011:107497.CrossRefPubMed Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part II-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011;2011:107497.CrossRefPubMed
24.
go back to reference SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2015 Sub (1973–2013) - Linked To County Attributes - Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission. SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2015 Sub (1973–2013) - Linked To County Attributes - Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission.
29.
go back to reference Ortega Hinojosa AM, Davies MM, Jarjour S, Burnett RT, Mann JK, Hughes E, Balmes JR, Turner MC, Jerrett M. Developing small-area predictions for smoking and obesity prevalence in the United States for use in environmental public health tracking. Environ Res. 2014;134:435–52.CrossRefPubMed Ortega Hinojosa AM, Davies MM, Jarjour S, Burnett RT, Mann JK, Hughes E, Balmes JR, Turner MC, Jerrett M. Developing small-area predictions for smoking and obesity prevalence in the United States for use in environmental public health tracking. Environ Res. 2014;134:435–52.CrossRefPubMed
33.
go back to reference Monroe AC, Ricketts TC, Savitz LA. Cancer in rural versus urban populations: a review. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 1992;8(3):212–20.CrossRef Monroe AC, Ricketts TC, Savitz LA. Cancer in rural versus urban populations: a review. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 1992;8(3):212–20.CrossRef
34.
go back to reference Lortet-Tieulent J, Goding Sauer A, Siegel RL, Miller KD, Islami F, Fedewa SA, Jacobs EJ, Jemal A. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016;176(12):1792–8.CrossRefPubMed Lortet-Tieulent J, Goding Sauer A, Siegel RL, Miller KD, Islami F, Fedewa SA, Jacobs EJ, Jemal A. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016;176(12):1792–8.CrossRefPubMed
35.
go back to reference Neri A, Stewart SL, Angell W. Radon control activities for lung cancer prevention in National Comprehensive Cancer Control Program Plans, 2005-2011. Prev Chronic Dis. 2013;10:E132.CrossRefPubMedPubMedCentral Neri A, Stewart SL, Angell W. Radon control activities for lung cancer prevention in National Comprehensive Cancer Control Program Plans, 2005-2011. Prev Chronic Dis. 2013;10:E132.CrossRefPubMedPubMedCentral
38.
go back to reference Larsson LS. The Montana radon study: social marketing via digital signage technology for reaching families in the waiting room. Am J Public Health. 2015;105(4):779–85.CrossRefPubMedPubMedCentral Larsson LS. The Montana radon study: social marketing via digital signage technology for reaching families in the waiting room. Am J Public Health. 2015;105(4):779–85.CrossRefPubMedPubMedCentral
39.
go back to reference Nissen MJ, Leach JW, Nissen JA, Swenson KK, Kehn H. Radon testing and mitigation: an intervention in a primary care setting. J Cancer Educ. 2012;27(3):566–72.CrossRefPubMed Nissen MJ, Leach JW, Nissen JA, Swenson KK, Kehn H. Radon testing and mitigation: an intervention in a primary care setting. J Cancer Educ. 2012;27(3):566–72.CrossRefPubMed
40.
go back to reference Butterfield PG, Hill W, Postma J, Butterfield PW, Odom-Maryon T. Effectiveness of a household environmental health intervention delivered by rural public health nurses. Am J Public Health. 2011;101(Suppl 1):S262–70.CrossRefPubMedPubMedCentral Butterfield PG, Hill W, Postma J, Butterfield PW, Odom-Maryon T. Effectiveness of a household environmental health intervention delivered by rural public health nurses. Am J Public Health. 2011;101(Suppl 1):S262–70.CrossRefPubMedPubMedCentral
Metadata
Title
A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population
Authors
Judy Y. Ou
Brynn Fowler
Qian Ding
Anne C. Kirchhoff
Lisa Pappas
Kenneth Boucher
Wallace Akerley
Yelena Wu
Kimberly Kaphingst
Garrett Harding
Deanna Kepka
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4002-9

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine